Key result
Pharmacologic inhibition of the peripheral and brain Angiotensin II system by AT(1) receptor blockade may have a role in the prevention and treatment of stress-related disorders.
Why the study?
Does AT(1) receptor blockade prevent stress-related disorders?
Does AT(1) receptor blockade prevent stress-related disorders?
AT(1) receptor blockade may offer therapeutic opportunities for the prevention and treatment of stress-related disorders by inhibiting the brain Angiotensin II system.
Hypothesis-generating for AT1 blockade in stress disorders; prospective trials needed before clinical consideration.
The presence of a brain Angiotensin II (Ang II) system, separated from and physiologically integrated with the peripheral, circulating renin-angiotensin system, is firmly established. Ang II is made in the brain and activates specific brain AT(1) receptors to regulate thirst and fluid metabolism. Some AT(1) receptors are located outside the blood-brain barrier and are sensitive to brain and circulating Ang II. Other AT(1) receptors, located inside the blood-brain barrier, respond to stimulation by Ang II of brain origin. AT(1) receptors in the subfornical organ, the hypothalamic paraventricular nucleus (PVN), and the median eminence are involved in the regulation of the stress response. In particular, AT(1) receptors in the PVN are under glucocorticoid control and regulate corticotrophin-releasing hormone (CRH) formation and release. In the PVN, restraint elicits a fast increase in AT(1) receptor mRNA expression. The expression of paraventricular AT(1) receptors is increased during repeated restraint and after 24 h of isolation stress, and their stimulation is essential for the hypothalamic-pituitary-adrenal axis activation, the hallmark of the stress response. Peripheral administration of an AT(1) receptor antagonist blocks peripheral and brain AT(1) receptors, prevents the sympathoadrenal and hormonal response to isolation stress, and prevents the gastric stress ulcers that are a characteristic consequence of cold-restraint stress. This evidence indicates that pharmacologic inhibition of the peripheral and brain Ang II system by AT(1) receptor blockade has a place in the prevention and treatment of stress-related disorders.
No takes yet. Share an insight, caveat, or question.
Saavedra et al. (2004) conducted a review in Stress-related disorders. AT(1) receptor antagonist was evaluated. Pharmacologic inhibition of the peripheral and brain Angiotensin II system by AT(1) receptor blockade may have a role in the prevention and treatment of stress-related disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: